Graham K Cooper's Net Worth

$7.15 Million

Estimate Recalculated Apr 2, 2025 09:11PM EST

Who is Graham K Cooper

Graham K Cooper has an estimated net worth of $7.15 Million. This is based on reported shares across multiple companies, which include Panacea Acquisition Corp, Orexigen Therapeutics, Inc., Receptos, Inc., Kezar Life Sciences, Inc., GERON CORP, Celladon Corp, Applied Molecular Transport Inc., Beam Therapeutics Inc., Unity Biotechnology, Inc., and ASSEMBLY BIOSCIENCES, INC..

SEC CIK

Graham K Cooper's CIK is 0001396943

Past Insider Trading and Trends

2021 was Graham K Cooper's most active year for acquiring shares with 7 total transactions. Graham K Cooper's most active month to acquire stocks was the month of May. 2009 was Graham K Cooper's most active year for disposing of shares, totalling 42 transactions. Graham K Cooper's most active month to dispose stocks was the month of November. 2014 saw Graham K Cooper paying a total of $255,000.00 for 96,945 shares, this is the most they've acquired in one year. In 2015 Graham K Cooper cashed out on 194,110 shares for a total of $39,632,441.55, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nuvation Bio Inc.

Investor
Updated Feb 26, 2021
Form 4
Feb 26, 2021
25.00K
Options
Feb 10
Form 3
Jun 30, 2020
Showing 2 results

Orexigen Therapeutics, Inc.

CFO and Treasurer
Updated Jan 20, 2011
Form 4
67.00K
Jan 20, 2011
67.00K
Grant
Jan 18
Form 4
45.00K
Sep 22, 2010
45.00K
Grant
Sep 20
Form 4
105.00K
Jan 26, 2010
105.00K
Grant
Jan 22
Form 4
-100.00%
-17.50K
$8.39
-$146.90K
Dec 23, 2009
Sale
Dec 21
Form 4
-33.44%
-82.50K
$4.46
-$607.86K
Dec 23, 2009
164.19K
Sale
Dec 21
Form 4
53.90K
Apr 27, 2009
53.90K
Grant
Apr 23
Form 4
42.45K
Jan 28, 2009
42.45K
Grant
Jan 26
Form 4
-3.24%
-8.26K
$6.35
-$93.33K
Aug 25, 2008
246.69K
Sale
ScheduledAug 21
Form 4
110.00K
Aug 18, 2008
110.00K
Grant
Aug 15
Form 4
45.00K
Dec 26, 2007
45.00K
Grant
Dec 20
Form 4
-1.54%
-4.00K
$7.40
-$53.56K
Dec 21, 2007
254.94K
Sale
ScheduledDec 20
Form 4
-1.52%
-4.00K
$7.72
-$56.17K
Nov 21, 2007
258.94K
Sale
ScheduledNov 20
Form 3
Apr 25, 2007
Showing 13 results

Receptos, Inc.

Chief Financial Officer
Updated Aug 27, 2015
Form 4
-100.00%
-194.11K
$210.21
-$39.63M
Aug 27, 2015
Disposition
Aug 27
Form 4
10.50K
Apr 03, 2015
10.50K
Grant
Apr 01
Form 4
-34.09%
-50.00K
$33.20
-$2.81M
Sep 17, 2014
96.67K
Sale
ScheduledSep 16
Form 4
36.95K
Apr 07, 2014
36.95K
Grant
Apr 03
Form 4
50.00K
Jul 19, 2013
50.00K
Grant
Jul 17
Form 3
May 08, 2013
Showing 6 results

Kezar Life Sciences, Inc.

Investor
Updated Jun 21, 2024
Form 4
50.00K
Jun 21, 2024
50.00K
Grant
Jun 20
Form 4
Jul 26, 2023
95.79K
Acq/Dis
Jul 24
Form 4
35.00K
Jun 16, 2023
35.00K
Grant
Jun 15
Form 4
26.00K
Jun 17, 2022
26.00K
Grant
Jun 16
Form 4
26.00K
May 13, 2022
26.00K
Grant
May 12
Form 4
26.00K
Jun 30, 2021
26.00K
Grant
Jun 28
Form 4
8.90K
Jun 26, 2020
8.90K
Grant
Jun 24
Form 4
8.90K
Jun 27, 2019
8.90K
Grant
Jun 25
Form 3
Jun 20, 2018
Showing 9 results

GERON CORP

EVP, Bus Dev & CFO
Updated May 18, 2012
Form 4
200.00K
May 18, 2012
200.00K
Grant
May 17
Form 4
500.00K
Jan 19, 2012
500.00K
Grant
Jan 18
Form 3
Jan 12, 2012
Showing 3 results

Celladon Corp

Investor
Updated Jun 05, 2015
Form 4
33.33%
10.00K
Jun 05, 2015
40.00K
Grant
Jun 04
Form 4
10.00K
May 21, 2014
10.00K
Grant
May 20
Form 3
Jan 29, 2014
Showing 3 results

Applied Molecular Transport Inc.

Investor
Updated Jan 31, 2022
Form 4
300.00K
Jan 31, 2022
300.00K
Grant
Jan 27
Form 4
15.11K
May 20, 2021
15.11K
Grant
May 18
Form 3
Jun 04, 2020
Showing 3 results

Beam Therapeutics Inc.

Investor
Updated Jun 07, 2024
Form 4
23.11K
Jun 07, 2024
23.11K
Grant
Jun 05
Form 4
16.53K
Jun 08, 2023
16.53K
Grant
Jun 06
Form 4
10.39K
Sep 02, 2022
10.39K
Grant
Sep 01
Form 4
-13.63%
-2.61K
$68.81
-$270.83K
Jul 08, 2021
16.56K
Sale
ScheduledJul 06
Form 4
-38.58%
-12.04K
$61.67
-$1.08M
Jun 30, 2021
19.18K
Sale
ScheduledJun 28
Form 4
6.88K
Jun 14, 2021
6.88K
Grant
Jun 10
Form 4
31.22K
Feb 11, 2020
31.22K
Grant
Feb 10
Form 3
Feb 05, 2020
Showing 8 results

Unity Biotechnology, Inc.

Investor
Updated Jun 28, 2021
Form 4
25.00K
Jun 28, 2021
25.00K
Grant
Jun 24
Form 4
25.00K
Jun 22, 2020
25.00K
Grant
Jun 18
Form 4
25.00K
Jun 24, 2019
109.75K
Grant
Jun 20
Form 4
10.17K
May 04, 2018
10.17K
Grant
May 02
Form 3
May 02, 2018
84.75K
Showing 5 results

ASSEMBLY BIOSCIENCES, INC.

See Remarks
Updated Apr 02, 2019
Form 4
52.50%
52.50K
Apr 02, 2019
152.50K
Grant
Mar 29
Form 4
100.00K
Dec 14, 2018
100.00K
Grant
Dec 12
Form 4
220.00K
Mar 12, 2018
220.00K
Grant
Mar 08
Form 3
Mar 12, 2018
Showing 4 results